Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 8-K Event Regulation FD disclosure · Other events
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 8-K Event Regulation FD disclosure · Other events
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 8-K Event Material agreement
  12. EFFECT Other Notice of Effectiveness
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. UPLOAD Other SEC-generated Letter
  15. S-3 Offering Registration Statement
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 30 · 584 filings